Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 2/20 | 0.56 |
| ▸ | XBP1 | P17861 | 1/20 | 0.56 |
| ▸ | PGR | P06401 | 1/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.55 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 1/20 | 0.55 |
| ▸ | HRH1 | P35367 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 4/20 | 0.54 |
| ▸ | CES1 | P23141 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20944778 | 0.90 | KMT2A (0.55) | KMT2ATDP1L3MBTL1LMNAMAPT | |
| SCHEMBL649287 | 0.90 | KMT2A (0.55) | KMT2ATDP1L3MBTL1LMNAMAPT | |
| SCHEMBL8823334 | 0.90 | KMT2A (0.55) | KMT2ATDP1L3MBTL1LMNAMAPT | |
| SCHEMBL3274886 | 0.90 | KMT2A (0.55) | KMT2ATDP1L3MBTL1LMNAMAPT | |
| SCHEMBL7867720 | 0.89 | CES2 (0.59) | KMT2ATDP1L3MBTL1LMNAMAPT | |
| SCHEMBL744661 | 0.89 | CES2 (0.63) | KMT2ATDP1L3MBTL1LMNAMAPT | |
| SCHEMBL28458281 | 0.88 | KMT2A (0.53) | KMT2ATDP1L3MBTL1LMNAMAPT | |
| SCHEMBL27493547 | 0.87 | CES2 (0.61) | KMT2ATDP1L3MBTL1LMNAMAPT | |
| SCHEMBL4971852 | 0.87 | CYP2C9 (0.52) | KMT2ATDP1L3MBTL1LMNAMAPT | |
| SCHEMBL28043313 | 0.87 | SMN1; SMN2 (0.53) | KMT2ATDP1L3MBTL1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200361892-A1 | POLYCYCLOCARBONATE COMPOUNDS AND POLYMERS FORMED THEREFROM | SWIMC LLC (US) | 2020-11-19 | — | — | US | claimed |
| US-10000461-B2 | Polycyclocarbonate compounds and polymers formed therefrom | SWIMC LLC (US) | 2018-06-19 | — | — | US | claimed |
| US-20170096408-A1 | POLYCYCLOCARBONATE COMPOUNDS AND POLYMERS FORMED THEREFROM | VALSPAR SOURCING, INC. (US) | 2017-04-06 | — | — | US | claimed |
| EP-3134484-A1 | POLYCYCLOCARBONATE COMPOUNDS AND POLYMERS FORMED THEREFROM | Valspar Sourcing, Inc. (US) | 2017-03-01 | — | — | EP | claimed |
| WO-2015164692-A1 | POLYCYCLOCARBONATE COMPOUNDS AND POLYMERS FORMED THEREFROM | VALSPAR SOURCING, INC. (US) | 2015-10-29 | — | — | WO | claimed |
| CN-102300549-B | Water-in-oil-type emulsion sunscreen cosmetic | SHISEIDO CO LTD | 2014-08-20 | — | — | CN | claimed |
| CN-103705398-A | Cosmetic emulsion with polyacrylate | BEIERSDORF AG | 2014-04-09 | — | — | CN | claimed |
| CN-102811703-A | Sun protection compositions | BAYER MATERIALSCIENCE AG | 2012-12-05 | — | — | CN | claimed |
| CN-102791248-A | Stabilization of cosmetic compositions | BASF SE | 2012-11-21 | — | — | CN | claimed |
| CN-101854904-B | Stabilization of cosmetic compositions | BASF SE | 2012-08-15 | — | — | CN | claimed |
| WO-2000023044-A1 | UV PROTECTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-04-27 | — | — | WO | claimed |
| CN-1235547-A | Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators | RECORDATI CHEM PHARM (CH) | 1999-11-17 | — | — | CN | claimed |
| CN-1222343-A | Photoprotective compositions and cosmetic uses | OREAL (FR) | 1999-07-14 | — | — | CN | claimed |
| CN-1208342-A | Stabilised sunscreen compositions | OREAL (FR) | 1999-02-17 | — | — | CN | claimed |
| CN-1116520-A | Skin protecting composition containing acid hydrophilic agent for cosmetic use and application of same | OREAL (FR) | 1996-02-14 | — | — | CN | claimed |
| EP-0516743-B1 | TRANSITION METAL CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION | EXXON CHEMICAL PATENTS INC (US) | 1994-09-14 | — | — | EP | claimed |
| EP-0516743-A1 | TRANSITION METAL CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION. | EXXON CHEMICAL PATENTS INC (US) | 1992-12-09 | — | — | EP | claimed |
| US-5145662-A | Ujv rad filters | L'OREAL (FR) | 1992-09-08 | — | — | US | claimed |
| WO-1991013074-A2 | TRANSITION METAL CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION | EXXON CHEMICAL PATENTS INC. (US) | 1991-09-05 | — | — | WO | claimed |
| US-5021595-A | Coordination catalysts based on a transition metal compound chelated with a ligand; durability; alpha-unsaturated hydrocarbons | EXXON CHEMICAL PATENTS INC. (US) | 1991-06-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170096408-A1 | POLYCYCLOCARBONATE COMPOUNDS AND POLYMERS FORMED THEREFROM | PICALM, PCLAF, PBRM1 | KMT2A 2565/4885TDP1 3119/4885L3MBTL1 4199/4885 |
| US-20200361892-A1 | POLYCYCLOCARBONATE COMPOUNDS AND POLYMERS FORMED THEREFROM | PICALM, PCLAF, PBRM1 | KMT2A 2565/4885TDP1 3119/4885L3MBTL1 4199/4885 |
| US-10000461-B2 | Polycyclocarbonate compounds and polymers formed therefrom | PICALM, PCLAF, PBRM1 | KMT2A 2565/4885TDP1 3119/4885L3MBTL1 4199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.